Publications by authors named "Hossein Sendi"

Claim this Profile
C
Correction to "Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo".
Feifei Yang, Yusra Medik, Liantao Li, Xi Tian, Dong Fu, Hossein Sendi

Small· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis.
Hossein Sendi, Mostafa Yazdimamaghani, Mengying Hu, Nikhila Sultanpuram, Jie Wang

Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo.
Feifei Yang, Yusra Medik, Liantao Li, Xi Tian, Dong Fu, Hossein Sendi

Small· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of liver microenvironment in hepatic metastasis.
Tovah Williamson, Nikhila Sultanpuram, Hossein Sendi

Clin Transl Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis C.
Hossein Sendi, Marjan Mehrab-Mohseni, Mark W Russo, Nury Steuerwald, Carl Jacobs

Clin Exp Gastroenterol Hepatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
Hossein Sendi, Ivy Mead, Meimei Wan, Marjan Mehrab-Mohseni, Kenneth Koch

PLoS One· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Hossein Sendi, Marjan Mehrab-Mohseni, David M Foureau, Sriparna Ghosh, Tracy L Walling

Liver Int· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
Tahereh Ghaziani, Hossein Sendi, Saeid Shahraz, Philippe Zamor, Herbert L Bonkovsky

World J Gastroenterol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection.
Hossein Khorramdelazad, Elham Hakimizadeh, Gholamhossein Hassanshahi, Mohammadtaghi Rezayati, Hossein Sendi

J Med Virol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C, porphyria cutanea tarda and liver iron: an update.
F Ryan Caballes, Hossein Sendi, Herbert L Bonkovsky

Liver Int· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis.
Hossein Sendi

Hepat Mon· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran.
Shokrollah Assar, Mohammad Kazemi Arababadi, Maryam Mohit, Behzad Nasiri Ahmadabadi, Paul Pumpens, Hossein Sendi

Clin Lab· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HFE Gene Mutations in Cryptogenic Cirrhosis Patients.
Hossein Sendi, Marjan Mehrab-Mohseni

Hepat Mon· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.
Marjan Mehrab-Mohseni, Hossein Sendi, Nury Steuerwald, Sriparna Ghosh, Laura W Schrum

World J Gastroenterol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
Hossein Sendi, Marjan Mehrab-Mohseni, Saeid Shahraz, Helene Norder, Seyed-Moayed Alavian

J Clin Virol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study.
Leila Alidoust, Maryam Zafarghandi, Mohammadreza Agah, Hossein Sendi, Seyed Moayed Alavian

Indian J Gastroenterol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection.
Tahereh Ghaziani, Seyed-Moayed Alavian, Mohammad R Zali, Saeid Shahraz, Mohammdreza Agah, Hossein Sendi

Hepatol Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D.
Hossein Sendi, Marjan Mehrab-Mohseni, Mohammad R Zali, Helene Norder, Lars O Magnius

J Gen Virol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemochromatosis mutations in Iranians with hepatitis B virus infection.
Hossein Sendi, Tahereh Ghaziani, Mohammad R Zali, Peyman Adibi, Mohammadreza Agah

Clin Infect Dis· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis